Janta X Ray Clinic Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 18-07-2024
- Paid Up Capital ₹ 9.00 M
as on 18-07-2024
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.88 M
as on 18-07-2024
- Satisfied Charges ₹ 114.70 M
as on 18-07-2024
- Revenue -1.41%
(FY 2023)
- Profit -25.48%
(FY 2023)
- Ebitda -22.21%
(FY 2023)
- Net Worth 7.29%
(FY 2023)
- Total Assets 35.46%
(FY 2023)
About Janta X Ray Clinic
The Corporate was formerly known as Organ Imaging Research Centre (I) P Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹3.89 Cr. The company has closed loans amounting to ₹11.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Monika Gupta, Veena Gupta, and Sameer Bhati serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PTC061085
- Company No.
061085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 1994
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Janta X Ray Clinic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Gupta  | Director | 30-Jun-2010 | Current |
| Veena Gupta | Director | 01-May-2017 | Current |
| Sameer Bhati | Director | 01-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Janta X Ray Clinic.
Janta X Ray Clinic Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.41% decrease. The company also saw a substantial fall in profitability, with a 25.48% decrease in profit. The company's net worth moved up by a moderate rise of 7.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janta X Ray Clinic?
In 2023, Janta X Ray Clinic had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Staredu Education And Training Institute Private Limited
Active
7 years 5 months Monika Gupta and Sameer Bhati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Sep 2023 | ₹0.76 M | Open |
Hdfc Bank Limited Creation Date: 31 Aug 2023 | ₹2.58 M | Open |
Hdfc Bank Limited Creation Date: 30 Jan 2017 | ₹7.44 M | Open |
How Many Employees Work at Janta X Ray Clinic?
Janta X Ray Clinic has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jul 12, 2010, Janta X Ray Clinic has raised a total of ₹ 10.4 Cr, with the most recent deal valued at ₹ 3.02 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
